Mylan Files Regulatory Notifications For Perrigo Takeover Offer
This article was originally published in The Tan Sheet
Mylan files notifications with FTC and DoJ required under U.S. antitrust laws. Mylan Chairman Robert says the filing is an “important step in our ongoing determination to make this compelling proposed combination a reality.”
You may also be interested in...
EU Regulatory Round-Up, February 2020: Brexit And Swixit Threaten Huge Disruption Amidst MDR Uncertainty
Complying with the EU’s new Medical Device Regulation would be hard enough. But more layers of uncertainty – especially Brexit and Swixit ̶ mean European medtech is navigating very turbulent waters right now.
Fresenius Kabi has reported sales ahead by 6% in 2019, as growth in emerging markets helped to offset a subdued increase in North America. Meanwhile, the firm has pushed back financial expectations for its biosimilars by a year.
Fresenius Kabi and Vifor Pharma have agreed to create a joint venture in China for intravenous iron products.